PPT-The Evolving Landscape of Post-Therapy Brain Tumor Imaging

Jeffrey Ware MD Ronald Wolf MD PhD Harish Poptani PhD Donald ORourke MD Suyash Mohan MD Neuroradiology Division Department of Radiology University of Pennsylvania ASNR 2015 Annual Meeting . Conventional Radiation Therapy 3 AMERICAN BRAIN TUMOR ASSOCIATION ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION Founded in 1973, the American Brain Tumor Association (ABTA) was the rst national nonp Katerina . Dikaiou. FP7/FMTXCT. Florian Stuker SNF. Steffi Lehmann NCCR/SNF. Divya. . Vats. FP7/LIVIMODE. Sandra . Buergi. NCCR/SNF. Manoj. . Desai. . FP7/LIVIMODE. Markus . Rudin. Institute . for. David Cheng, MD, PhD. Division Chief of Nuclear Medicine and Molecular Imaging. Sidra Medical and Research Center. Doha, Qatar. Disclosure. Avid Radiopharmaceuticals: consultant. Navidea. Radiopharmaceuticals: consultant. David Cheng, MD, PhD. Division Chief of Nuclear Medicine and Molecular Imaging. Sidra Medical and Research Center. Doha, Qatar. Disclosure. Avid Radiopharmaceuticals: consultant. Navidea. Radiopharmaceuticals: consultant. Presented by [NAME]. Brain Tumor Impact in the United States. More than 79,000 . new cases of primary brain tumors will be diagnosed this year. More than . 4,800 . children between the ages of 0 – 19 will be diagnosed with a brain tumor this year. Brain Tumor Impact in the United States. More than 79,000 . new cases of primary brain tumors will be diagnosed this year. More than . 4,800 . children between the ages of 0 – 19 will be diagnosed with a brain tumor this year. Understanding the Landscape and Establishing Reporting Processes. Andrea Sipin-Baliwas. Los Angeles Cancer Surveillance Program. University of Southern California. NAACCR/IACR Meeting. June 11, 2019. HIGH GR B Y B O B CA R U TH ER S, CST, PHD ASTROCY T B IOLO G Y , P A TH O LO G Y , D IA G N O STIC S , A N D TR E A TM E N T PAR T 2 Carmustine (BCNU) (CPT-11) Atropine What do we know about childhood brain tumors? What do we know about childhood brain tumors? Brain tumors represent about 25% of all childhood cancer diagnoses. patients under 20 years of age ea under 158 3601_e05_p158-170 2/15/02 4:31 PM Page 158 progress at all or progress over many years. Poste-virtually indistinguishable from a primary hypothala- 3601_e05_p158-170 2/15/02 4:31 PM Page 159 David . Maung. , Tristan . Reichardt. , Dan . Bibyk. , Juan Roman. Department of Computer Science and Engineering. The Ohio State University. The Problem. Constraint-Induced . therapy is unavailable to most patients due to its cost, travel/scheduling demands, and . Primary :. 1-Gliomas. (most common primary brain tumor) . . 50%. . Astrocytomas. Oligodendrogliomas. Ependymomas. 2-Meningioma. . Presented by [NAME]. Overview of cognitive/emotional symptoms. Affects more than half (50%) of patients with malignant brain tumors. Causes. From the tumor itself: symptoms based on tumor size/location. BIOE 477/598DP. High . echogenicity. Low attenuation. Low blood solubility. Low diffusivity. Ability to traverse pulmonary system. Lack of biological effects in repeat exposures. Ideal Characteristics of an Ultrasound Probe.